472 related articles for article (PubMed ID: 17897305)
1. Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations.
Pomp ER; le Cessie S; Rosendaal FR; Doggen CJ
Br J Haematol; 2007 Oct; 139(2):289-96. PubMed ID: 17897305
[TBL] [Abstract][Full Text] [Related]
2. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
Aznar J; Vayá A; Estellés A; Mira Y; Seguí R; Villa P; Ferrando F; Falcó C; Corella D; España F
Haematologica; 2000 Dec; 85(12):1271-6. PubMed ID: 11114134
[TBL] [Abstract][Full Text] [Related]
3. Smoking increases the risk of venous thrombosis and acts synergistically with oral contraceptive use.
Pomp ER; Rosendaal FR; Doggen CJ
Am J Hematol; 2008 Feb; 83(2):97-102. PubMed ID: 17726684
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in the protein C gene as risk factor for venous thrombosis.
Pomp ER; Doggen CJ; Vos HL; Reitsma PH; Rosendaal FR
Thromb Haemost; 2009 Jan; 101(1):62-7. PubMed ID: 19132190
[TBL] [Abstract][Full Text] [Related]
5. Effect of Factor V Leiden and prothrombin G20210-->A mutations on thromboembolic risk in the national surgical adjuvant breast and bowel project breast cancer prevention trial.
Abramson N; Costantino JP; Garber JE; Berliner N; Wickerham DL; Wolmark N
J Natl Cancer Inst; 2006 Jul; 98(13):904-10. PubMed ID: 16818854
[TBL] [Abstract][Full Text] [Related]
6. High risk of cerebral-vein thrombosis in carriers of a prothrombin-gene mutation and in users of oral contraceptives.
Martinelli I; Sacchi E; Landi G; Taioli E; Duca F; Mannucci PM
N Engl J Med; 1998 Jun; 338(25):1793-7. PubMed ID: 9632445
[TBL] [Abstract][Full Text] [Related]
7. Venous thromboembolism in young women; role of thrombophilic mutations and oral contraceptive use.
Legnani C; Palareti G; Guazzaloca G; Cosmi B; Lunghi B; Bernardi F; Coccheri S
Eur Heart J; 2002 Jun; 23(12):984-90. PubMed ID: 12069454
[TBL] [Abstract][Full Text] [Related]
8. AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms.
Miñano A; Ordóñez A; España F; González-Porras JR; Lecumberri R; Fontcuberta J; Llamas P; Marín F; Estellés A; Alberca I; Vicente V; Corral J
Haematologica; 2008 May; 93(5):729-34. PubMed ID: 18387978
[TBL] [Abstract][Full Text] [Related]
9. Venous thrombosis, oral contraceptives and high factor VIII levels.
Bloemenkamp KW; Helmerhorst FM; Rosendaal FR; Vandenbroucke JP
Thromb Haemost; 1999 Sep; 82(3):1024-7. PubMed ID: 10494758
[TBL] [Abstract][Full Text] [Related]
10. Overweight, obesity, and the risk of recurrent venous thromboembolism.
Eichinger S; Hron G; Bialonczyk C; Hirschl M; Minar E; Wagner O; Heinze G; Kyrle PA
Arch Intern Med; 2008 Aug; 168(15):1678-83. PubMed ID: 18695082
[TBL] [Abstract][Full Text] [Related]
11. Prothrombotic mutations, hormone therapy, and venous thromboembolism among postmenopausal women: impact of the route of estrogen administration.
Straczek C; Oger E; Yon de Jonage-Canonico MB; Plu-Bureau G; Conard J; Meyer G; Alhenc-Gelas M; Lévesque H; Trillot N; Barrellier MT; Wahl D; Emmerich J; Scarabin PY;
Circulation; 2005 Nov; 112(22):3495-500. PubMed ID: 16301339
[TBL] [Abstract][Full Text] [Related]
12. Venous thromboembolic disease in users of low-estrogen combined estrogen-progestin oral contraceptives.
Sidney S; Petitti DB; Soff GA; Cundiff DL; Tolan KK; Quesenberry CP
Contraception; 2004 Jul; 70(1):3-10. PubMed ID: 15208046
[TBL] [Abstract][Full Text] [Related]
13. Conjugated equine estrogen, esterified estrogen, prothrombotic variants, and the risk of venous thrombosis in postmenopausal women.
Smith NL; Heckbert SR; Lemaitre RN; Reiner AP; Lumley T; Rosendaal FR; Psaty BM
Arterioscler Thromb Vasc Biol; 2006 Dec; 26(12):2807-12. PubMed ID: 16973976
[TBL] [Abstract][Full Text] [Related]
14. Oral contraceptives and the risk of myocardial infarction.
Tanis BC; van den Bosch MA; Kemmeren JM; Cats VM; Helmerhorst FM; Algra A; van der Graaf Y; Rosendaal FR
N Engl J Med; 2001 Dec; 345(25):1787-93. PubMed ID: 11752354
[TBL] [Abstract][Full Text] [Related]
15. An unfavorable combination of Factor V Leiden with age, weight, and blood group causes high risk of pregnancy-associated venous thrombosis: a population-based nested case-control study.
Hiltunen L; Rautanen A; Rasi V; Kaaja R; Kere J; Krusius T; Vahtera E; Paunio M
Thromb Res; 2007; 119(4):423-32. PubMed ID: 16765424
[TBL] [Abstract][Full Text] [Related]
16. Site of venous thromboembolism and prothrombotic mutations according to body mass index. Results from the EDITH study.
Delluc A; Le Moigne E; Tromeur C; Noel-Savina E; Couturaud F; Mottier D; Le Gal G; Lacut K
Br J Haematol; 2011 Aug; 154(4):486-91. PubMed ID: 21671893
[TBL] [Abstract][Full Text] [Related]
17. D-dimer as a risk factor for deep vein thrombosis: the Leiden Thrombophilia Study.
Andreescu AC; Cushman M; Rosendaal FR
Thromb Haemost; 2002 Jan; 87(1):47-51. PubMed ID: 11858188
[TBL] [Abstract][Full Text] [Related]
18. Minor injuries as a risk factor for venous thrombosis.
van Stralen KJ; Rosendaal FR; Doggen CJ
Arch Intern Med; 2008 Jan; 168(1):21-6. PubMed ID: 18195191
[TBL] [Abstract][Full Text] [Related]
19. Minor events and the risk of deep venous thrombosis.
Eekhoff EM; Rosendaal FR; Vandenbroucke JP
Thromb Haemost; 2000 Mar; 83(3):408-11. PubMed ID: 10744145
[TBL] [Abstract][Full Text] [Related]
20. Body mass index, weight, and oral contraceptive failure risk.
Holt VL; Scholes D; Wicklund KG; Cushing-Haugen KL; Daling JR
Obstet Gynecol; 2005 Jan; 105(1):46-52. PubMed ID: 15625141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]